icon-close
fren

On June 16 2025, SCN was pleased to allocate $13.5M to support 36 research projects and clinical trials across the country, with 63 partner organizations committing $19.5M of in kind or cash support.

This investment is the result of SCN’s first of two funding competitions for the 2025-2029 period to support world-class regenerative medicine research and clinical trials. The projects and clinical trials cover 14 different disease areas and illnesses such as, brain disorders, diabetes, heart and lung disease, cancer and much more.

As part of this funding competition, which opened in September 2024, 111 applications were received for consideration. These applications were assessed through an international peer review for scientific merit, and then considered for strategic fit by SCN’s Research Management Committee. To read more about SCN’s Research Funding Program and Peer Review Process, click here.

SCN 2025-2029 Round 1 Funding Results:

Accelerating Clinical Translation Awards


Clinical Trials Awards


Early Career Researcher Jump Start Awards


Fueling Biotechnology Partnerships Awards


Impact Awards


Impact Awards: ELSI Stream